Back to results
US 2006/0052391 A1Published application
Method for the treatment of attention deficit hyperactivity disorder
AssigneeBoehringer Ingelheim International GmbH
InventorMikael Dolsten
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the treatment of Attention Deficit Hyperactivity Disorder comprising the administration of a therpeutically effective amount of flibanserin.
Claims3
1) A method for the treatment of Attention Deficit Hyperactivity Disorder comprising administering a therapeutically effective amount of flibanserin, or a pharmacologically acceptable acid addition salt thereof.
Dependencies are inferred from the claim text.